BEXINIB 1MG

Bexinib 1mg Tablet is an anticancer medication classified as a tyrosine kinase inhibitor, with Axitinib as its active ingredient. It is prescribed for the treatment of advanced kidney cancer, also referred to as renal cell carcinoma, which arises from the kidney cells.

While undergoing treatment with Bexinib 1mg Tablet, it is advised against having any surgical procedures due to the increased risk of bleeding. Inform your physician prior to any surgery or dental work. Seek immediate medical assistance if you notice symptoms such as itching, changes in vision, confusion, or dizziness. This medication may pose risks to an unborn child. Notify your healthcare provider before starting this treatment if you are pregnant or planning to conceive. It is recommended for both men and women to use effective contraceptive methods during treatment and for one week following the last dose of Bexinib 1mg Tablet. Additionally, avoid breastfeeding while on this medication, as it can affect the baby’s growth and development through breast milk. If you experience mouth sores, weight loss, or itchy skin, consult your doctor.

Bexinib 1mg Tablets are not suitable for adolescents and children under 18 years of age. If you experience shortness of breath, chest pain, or a worsening cough, contact your doctor immediately. Throughout the treatment with Bexinib 1mg Tablet, your physician may regularly check your white blood cell counts, platelets, blood sugar levels, electrolytes, and kidney function to avert serious complications. Some gastrointestinal symptoms, including diarrhea, nausea, vomiting, and constipation, may also occur during treatment, and it is important to report these to your doctor promptly.